1 recruiting, 1 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 1, Unknown 1 |
Follow Artificial Intelligence: new trials by email Literature Review of Artificial Intelligence trials Research Report on Artificial Intelligence
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Glioma Adaptive Radiotherapy With Development of an Artificial Intelligence Workflow Adaptive radiotherapy - Diffuse Glioma, Glioblastoma | Phase 2 | Recruiting | Tata Memorial Centre | 60 | 2026-07-27 | 2026-08-17 |
| Neoadjuvant Camrelizumab, Nab-paclitaxel and Carboplatin in Stage IB-IIIA NSCLC Camrelizumab + Nab-paclitaxel + Carboplatin - Lung Cancer, Non-small Cell, Artificial Intelligence | Phase 2 | Unknown | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 40 | 2020-08-01 | 2021-06-23 |
Carcinoma, Non-Small-Cell Lung (1) · Glioblastoma (1)
Neoplasms (2) · Astrocytoma (1) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Glioma (1) · Lung Diseases (1) · Lung Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Nerve Tissue (1) · Neoplasms, Neuroepithelial (1) · Neuroectodermal Tumors (1) · Respiratory Tract Diseases (1)
130-nm albumin-bound paclitaxel (1) · Carboplatin (1) · camrelizumab (1)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1) · Tata Memorial Centre (1)
China (1) · India (1)
Archya Dasgupta (1)